Advances in Cancer Management 2012
DOI: 10.5772/24866
|View full text |Cite
|
Sign up to set email alerts
|

Testosterone for the Treatment of Mammary and Prostate Cancers: Historical Perspectives and New Directions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 79 publications
(82 reference statements)
0
1
0
Order By: Relevance
“…We found that LSS‐stressed HUVECs expressing either sh WWP2 or the RAP1‐K31R mutant showed higher levels of ROS, peroxidized lipids, and oxidative DNA damage ( Figure 4 a,b,c ), indicating that the dysregulation of RAP1 ubiquitination results in increased ROS production. Given that a previous study demonstrated that treatment with Tranilast, an antioxidant and immunosuppressive drug, [ 47 ] rescued barrier function in KRIT1 ‐deficient cells dysregulated by high ROS production, [ 48 ] we examined the effect of Tranilast in our system. Similar to the effect observed in KRIT1 ‐deficient cells, Tranilast treatment normalized ROS levels and reduced permeability in HUVECs with WWP2 knockdown or expression of the RAP1‐K31R mutant (Figure 4c,d ).…”
Section: Resultsmentioning
confidence: 99%
“…We found that LSS‐stressed HUVECs expressing either sh WWP2 or the RAP1‐K31R mutant showed higher levels of ROS, peroxidized lipids, and oxidative DNA damage ( Figure 4 a,b,c ), indicating that the dysregulation of RAP1 ubiquitination results in increased ROS production. Given that a previous study demonstrated that treatment with Tranilast, an antioxidant and immunosuppressive drug, [ 47 ] rescued barrier function in KRIT1 ‐deficient cells dysregulated by high ROS production, [ 48 ] we examined the effect of Tranilast in our system. Similar to the effect observed in KRIT1 ‐deficient cells, Tranilast treatment normalized ROS levels and reduced permeability in HUVECs with WWP2 knockdown or expression of the RAP1‐K31R mutant (Figure 4c,d ).…”
Section: Resultsmentioning
confidence: 99%